本資料は、掲載誌(URI)等のリンク先にある学位授与機関のWebサイトやCiNii Dissertationsから、本文を自由に閲覧できる場合があります。
Effects of ITPA and IFNL4 polymorphism during simeprevir, peg-interferon, and ribavirin combination and sofosbuvir and ribavirin combination treatment for chronic hepatitis C
Available in National Diet Library
Find on the publisher's website
国立国会図書館デジタルコレクション
Digital data available
Check on the publisher's website
DOI[10.1111/hepr.12681]to the data of the same series
Search by Bookstore
Read this material in an accessible format.
Search by Bookstore
Read in Disability Resources
- Other Services
Bibliographic Record
You can check the details of this material, its authority (keywords that refer to materials on the same subject, author's name, etc.), etc.
- Material Type
- 博士論文
- Author/Editor
- 盛生, 慶
- Publication, Distribution, etc.
- Publication Date
- 2018
- Publication Date (W3CDTF)
- 2018
- Alternative Title
- C型慢性肝炎患者に対するシメプレビル/ペグインターフェロン/リバビリン併用療法、ソホスブビル/リバビリン併用療法におけるITPA, IFNL4遺伝子多型の影響
- Degree grantor/type
- 広島大学
- Date Granted
- 2018-03-23
- Date Granted (W3CDTF)
- 2018-03-23